Strategic partnership between Mission Bio and Fulgent Genetics (FLGT) will enable drug developers to leverage single-cell multi-omics for biomarker discovery, clinical research, and single-cell MRD ...

Looking to expand its legacy in metabolic conditions, Novo Nordisk has inked a multiyear research pact with Variant Bio to better understand the genetics underlying disease across diverse populations.

Expert details it is not only modern technology that enhance the role of preventive healthcare but simple yet effective measures like early detection, accessible and understanding the broad population ...

SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (“Ligand,” the “Company” or “we”) announced that it has entered into a merger agreement, pursuant to which its ...